Evidence mapPaperPMID 41392162Full record

ArticleEuropean journal of medical research2025

Identification and validation of efferocytosis-related biomarkers for the diagnosis of atherosclerosis based on bioinformatics and machine learning.

Xingyu Fu, Ao Yin, Chao Wang, Xinxin Liu, Min Li, Dan Liu, Xue Guan, Xiuru Guan

Abstract read
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingyu FuDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Ao YinDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Chao WangDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Xinxin LiuDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Min LiDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Dan LiuDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Xue GuanDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China.
Xiuru GuanDepartment of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, No. 23 Postal Street, Nangang District, Harbin, 150001, Heilongjiang, China. gxr0451@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtherosclerosis is a primary contributor to worldwide morbidity and mortality. Failure to timely clear apoptotic cells can trigger a cascade reaction, where the necrotic core expands until the fibrous cap is ruptured, and atherosclerotic plaques become vulnerable. Efferocytosis is an important method for recognizing and eliminating apoptotic cells. Nevertheless, the specific effect of efferocytosis on atherosclerosis remains uncertain. This study aimed to identify and verify the relevant characteristics of efferocytosis for detecting atherosclerosis.

methodsThe data of gene expression patterns of atherosclerosis were sourced from the Gene Expression Omnibus (GEO) database, and the differential expression analyses of efferocytosis-related genes (EFRGs) were performed between the atherosclerosis samples and the control samples. Subsequently, protein-protein interaction (PPI), correlation analysis, and functional enrichment analysis were performed to reveal the interaction between molecules as well as their pathways. Machine learning (ML) was employed to determine hub genes to construct a clinical prediction model. At the same time, immune infiltration, single-cell transcriptome analysis, and cell experiments were conducted in both atherosclerosis and control samples to provide a reference for the immune cell landscape and the cell heterogeneity under this condition.

resultsThe study revealed that 14 genes were closely related to efferocytosis in atherosclerosis. Among them, an ML model was used to screen 5 potential diagnostic biomarkers, including tumor necrosis factor (TNF), apolipoprotein E (ApoE), neutrophil cytosolic factor 1 (NCF1), triggering receptor expressed on myeloid cells 2 (TREM2), and chitinase-3 like-protein-1 (CHI3L1). Subsequent external validation indicated that, except for TNF, the other 4 genes were all upregulated. From the cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) analysis, those 5 genes were all significantly associated with various immune cells. Further single-cell RNA sequencing (scRNA-seq) analysis demonstrated that those 5 genes were selectively upregulated in the macrophages of atherosclerosis lesions, which was supported by mRNA levels in cell experiments.

conclusionsThis study clarified the association between atherosclerosis and efferocytosis, and established an effective diagnostic model. Moreover, potential treatment targets for atherosclerosis were identified, offering new insights into the potential mechanism of atherosclerosis.

Indexed as

AtherosclerosisComputational BiologyMachine LearningPhagocytosisBiomarkersEfferocytosisGene Expression ProfilingHumansProtein Interaction MapsBiomarkersAtherosclerosisBioinformaticsEfferocytosisMachine learning

Identifiers

PMID41392162
PMCPMC12771947

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.